These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 32802188)

  • 1. Targeting phosphatidylserine for Cancer therapy: prospects and challenges.
    Chang W; Fa H; Xiao D; Wang J
    Theranostics; 2020; 10(20):9214-9229. PubMed ID: 32802188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blocking antibody-mediated phosphatidylserine enhances cancer immunotherapy.
    Zhang J; Dai Z; Yan C; Wang D; Tang D
    J Cancer Res Clin Oncol; 2021 Dec; 147(12):3639-3651. PubMed ID: 34499223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphatidylserine: A cancer cell targeting biomarker.
    Sharma B; Kanwar SS
    Semin Cancer Biol; 2018 Oct; 52(Pt 1):17-25. PubMed ID: 28870843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mobilizing phospholipids on tumor plasma membrane implicates phosphatidylserine externalization blockade for cancer immunotherapy.
    Wang W; Wu S; Cen Z; Zhang Y; Chen Y; Huang Y; Cillo AR; Prokopec JS; Quarato G; Vignali DAA; Stewart-Ornstein J; Li S; Lu B; Gong YN
    Cell Rep; 2022 Nov; 41(5):111582. PubMed ID: 36323258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer.
    Birge RB; Boeltz S; Kumar S; Carlson J; Wanderley J; Calianese D; Barcinski M; Brekken RA; Huang X; Hutchins JT; Freimark B; Empig C; Mercer J; Schroit AJ; Schett G; Herrmann M
    Cell Death Differ; 2016 Jun; 23(6):962-78. PubMed ID: 26915293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphatidylserine exposure in living cells.
    Shin HW; Takatsu H
    Crit Rev Biochem Mol Biol; 2020 Apr; 55(2):166-178. PubMed ID: 32408772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of betabodies: The next generation of phosphatidylserine targeting agents.
    Phinney NZ; Huang X; Toombs JE; Brekken RA
    J Biol Chem; 2024 Sep; 300(9):107681. PubMed ID: 39159812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphatidylserine, a death knell.
    Schlegel RA; Williamson P
    Cell Death Differ; 2001 Jun; 8(6):551-63. PubMed ID: 11536005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The central role of phosphatidylserine in the phagocytosis of apoptotic thymocytes.
    Schlegel RA; Callahan MK; Williamson P
    Ann N Y Acad Sci; 2000; 926():217-25. PubMed ID: 11193037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TIMs, TAMs, and PS- antibody targeting: implications for cancer immunotherapy.
    Dayoub AS; Brekken RA
    Cell Commun Signal; 2020 Feb; 18(1):29. PubMed ID: 32087708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody targeting of phosphatidylserine for the detection and immunotherapy of cancer.
    Belzile O; Huang X; Gong J; Carlson J; Schroit AJ; Brekken RA; Freimark BD
    Immunotargets Ther; 2018; 7():1-14. PubMed ID: 29417044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage recognition of externalized phosphatidylserine and phagocytosis of apoptotic Jurkat cells--existence of a threshold.
    Borisenko GG; Matsura T; Liu SX; Tyurin VA; Jianfei J; Serinkan FB; Kagan VE
    Arch Biochem Biophys; 2003 May; 413(1):41-52. PubMed ID: 12706340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminophospholipid translocase TAT-1 promotes phosphatidylserine exposure during C. elegans apoptosis.
    Züllig S; Neukomm LJ; Jovanovic M; Charette SJ; Lyssenko NN; Halleck MS; Reutelingsperger CP; Schlegel RA; Hengartner MO
    Curr Biol; 2007 Jun; 17(11):994-9. PubMed ID: 17540571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of phosphatidylserine exposure and phagocytosis of apoptotic T lymphocytes.
    Verhoven B; Krahling S; Schlegel RA; Williamson P
    Cell Death Differ; 1999 Mar; 6(3):262-70. PubMed ID: 10200577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immune functions of phosphatidylserine in membranes of dying cells and microvesicles.
    Frey B; Gaipl US
    Semin Immunopathol; 2011 Sep; 33(5):497-516. PubMed ID: 20941495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gla-domain mediated targeting of externalized phosphatidylserine for intracellular delivery.
    Hardy J; Bauzon M; Chan CKF; Makela AV; Kanada M; Schneider D; Blankenberg F; Contag CH; Hermiston T
    FASEB J; 2023 Aug; 37(8):e23113. PubMed ID: 37486772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biology of phosphatidylserine (PS): basic physiology and implications in immunology, infectious disease, and cancer.
    Calianese DC; Birge RB
    Cell Commun Signal; 2020 Mar; 18(1):41. PubMed ID: 32160904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suicidal membrane repair regulates phosphatidylserine externalization during apoptosis.
    Mirnikjoo B; Balasubramanian K; Schroit AJ
    J Biol Chem; 2009 Aug; 284(34):22512-6. PubMed ID: 19561081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological Function and Immunotherapy Utilizing Phosphatidylserine-based Nanoparticles.
    Glassman FY; Dingman R; Yau HC; Balu-Iyer SV
    Immunol Invest; 2020 Oct; 49(7):858-874. PubMed ID: 32204629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SapC-DOPS - a Phosphatidylserine-targeted Nanovesicle for selective Cancer therapy.
    N'Guessan KF; Patel PH; Qi X
    Cell Commun Signal; 2020 Jan; 18(1):6. PubMed ID: 31918715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.